- βDexcom G7 offers the fastest 30-minute warm-up time of any FDA-cleared CGM
- βAbbott Libre 3 Plus provides up to 15 days of wear for fewer sensor changes
- βBoth devices deliver clinical-grade accuracy with MARD scores below 8.5%
Dexcom G7 vs Abbott Libre 3 Plus: 2025 Head-to-Head
Continuous glucose monitors (CGMs) have transformed diabetes management, and in 2025, two devices dominate the conversation: the Dexcom G7 and the Abbott Libre 3 Plus. Both offer real-time glucose readings, smartphone connectivity, and impressive accuracy β but they differ in meaningful ways. Here's a thorough comparison to help you make the best choice for your lifestyle.
Sensor Size and Wearability
The Dexcom G7 features a compact, all-in-one design that combines the sensor and transmitter in a single unit. It's roughly 60% smaller than its predecessor, the G6, and sits comfortably on the upper arm or abdomen. The Abbott Libre 3 Plus is equally impressive in size β it's about the size of two stacked pennies and is among the smallest CGMs available. Both sensors are discreet and water-resistant, making them suitable for active users.
Accuracy
Accuracy is measured by Mean Absolute Relative Difference (MARD) β the lower, the better. The Dexcom G7 boasts a MARD of approximately 8.2%, while the Abbott Libre 3 Plus comes in at around 7.9%, making both highly accurate clinical-grade devices. For most users, the real-world difference is negligible, but the Libre 3 Plus holds a slight statistical edge.
Warm-Up Time
One of the Dexcom G7's standout features is its 30-minute warm-up period, which is the fastest among FDA-cleared CGMs. The Abbott Libre 3 Plus requires approximately 60 minutes before readings begin. If you replace sensors frequently or want faster startup, the G7 wins here.
Wear Duration
The Dexcom G7 is approved for a 10-day wear period plus a 12-hour grace period, giving users a little flexibility. The Libre 3 Plus extends wear up to 15 days, making it one of the longest-lasting CGMs on the market. For users who dislike frequent sensor changes, the Libre 3 Plus has a clear advantage.
Alerts and Alarms
Dexcom G7 offers highly customizable alerts for high glucose, low glucose, and urgent low warnings, including a predictive low alert that warns you up to 20 minutes in advance. The Libre 3 Plus also provides real-time alerts, including optional high and low alarms β a major upgrade from earlier Libre models that required scanning. Both systems now support continuous Bluetooth streaming to compatible smartphones.
App and Connectivity
Both devices connect to user-friendly smartphone apps available on iOS and Android. Dexcom's app integrates seamlessly with Apple Watch and various insulin pump systems, including closed-loop automated insulin delivery (AID) systems. The LibreLink app is clean and intuitive, and the Libre 3 Plus also supports integration with some AID systems. For advanced users building a tech ecosystem, Dexcom's broader compatibility may be a deciding factor.
Cost and Insurance
Pricing varies by country, insurance plan, and pharmacy. Generally, both sensors are available through major insurers in the US, with copays depending on your coverage tier. Diabetes supply specialists like mdsdiabetes.com can help you navigate insurance options and compare out-of-pocket costs for both devices, making the financial side of your decision easier to manage.
Which CGM Is Right for You?
Choosing between the Dexcom G7 and Abbott Libre 3 Plus depends on your priorities:
- Choose Dexcom G7 if you want faster warm-up times, robust alert customization, and broader AID system compatibility.
- Choose Libre 3 Plus if you prefer longer sensor wear, a slightly lower MARD, and an ultra-slim profile.
Both are excellent choices in 2025. Consulting your endocrinologist or diabetes care team is always the best first step to finding the sensor that fits your specific health goals and daily routine.